OCC.AX ASX
Orthocell Limited
1W: +2.7%
1M: +4.8%
3M: -12.6%
YTD: -24.0%
1Y: -33.3%
3Y: +114.1%
5Y: +60.0%
A$0.75 ($0.52)
-0.01 (-1.32%)
Weekly Expected Move ±6.5%
A$1
A$1
A$1
A$1
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$13M
-53.4% ▼
Capital Expenditures
$1M
-209.1% ▼
5Y CAGR: +42.6%
Free Cash Flow
-$14M
-59.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$19M
-339.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$6M | -$7M | $0 | -$14M |
| Depreciation & Amort. | $349K | $554K | $517K | $0 | $864K |
| Stock-Based Comp. | $501K | $2M | $0 | $0 | $0 |
| Change in Working Capital | $2M | $18M | -$2M | -$2M | -$4M |
| Other Non-Cash Items | $22M | -$16M | $2M | -$6M | $4M |
| Operating Cash Flow | -$6M | $15M | -$7M | -$9M | -$13M |
| — Investing Activities — | |||||
| Capital Expenditures | -$535K | -$632K | -$927K | -$260K | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$43M |
| Investment Sales | $0 | $0 | $0 | $0 | $7M |
| Other Investing | -$18K | -$18K | -$15K | -$99K | $0 |
| Investing Cash Flow | -$535K | -$632K | -$942K | -$359K | -$37M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $1M |
| Stock Repurchased | $0 | $0 | -$123K | -$882K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$147K | -$165K | $3M | $18M | -$241K |
| Financing Cash Flow | $1M | -$165K | $3M | $17M | $31M |
| Net Change in Cash | -$5M | $14M | -$4M | $8M | -$19M |
| Cash End of Period | $11M | $25M | $21M | $29M | $9M |
| Free Cash Flow | -$7M | $14M | -$7M | -$9M | -$14M |